Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali
Abstract Background In 2006, the National Malaria Control Program in Mali recommended artemisinin-based combination therapy as the first-line treatment for uncomplicated malaria. Since the introduction of artemisinin-based combination therapy, few reports are available on the level of resistance of...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_8ba7142356c048e289f3a19dc43e0a01 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Karim Traoré |e author |
700 | 1 | 0 | |a Seidina A. S. Diakité |e author |
700 | 1 | 0 | |a Sekou Bah |e author |
700 | 1 | 0 | |a Drissa S. Konaté |e author |
700 | 1 | 0 | |a Djeneba Dabitao |e author |
700 | 1 | 0 | |a Ibrahim Sanogo |e author |
700 | 1 | 0 | |a Modibo Sangaré |e author |
700 | 1 | 0 | |a Souleymane Dama |e author |
700 | 1 | 0 | |a Bourama Keita |e author |
700 | 1 | 0 | |a Mory Doumbouya |e author |
700 | 1 | 0 | |a Merepen A. Guindo |e author |
700 | 1 | 0 | |a Seydou Doumbia |e author |
700 | 1 | 0 | |a Mahamadou Diakité |e author |
245 | 0 | 0 | |a Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali |
260 | |b Adis, Springer Healthcare, |c 2020-06-01T00:00:00Z. | ||
500 | |a 10.1007/s40268-020-00313-4 | ||
500 | |a 1174-5886 | ||
500 | |a 1179-6901 | ||
520 | |a Abstract Background In 2006, the National Malaria Control Program in Mali recommended artemisinin-based combination therapy as the first-line treatment for uncomplicated malaria. Since the introduction of artemisinin-based combination therapy, few reports are available on the level of resistance of Plasmodium falciparum to the most common anti-malarial drugs in Mali. Methods From 2016 to 2017, we assessed the ex-vivo drug sensitivity of P. falciparum isolates in Kéniéroba, a village located in a rural area of southern Mali. We collected P. falciparum isolates from malaria-infected children living in Kéniéroba. The isolates were tested for ex-vivo sensitivity to commonly used anti-malarial drugs, namely chloroquine, quinine, amodiaquine, mefloquine, lumefantrine, dihydroartermisinin, and piperaquine. We used the 50% inhibitory concentration determination method, which is based on the incorporation of SYBR® Green into the parasite's genetic material. Results Plasmodium falciparum isolates were found to have a reduced ex-vivo sensitivity to quinine (25.7%), chloroquine (12.2%), amodiaquine (2.7%), and mefloquine (1.3%). In contrast, the isolates were 100% sensitive to lumefantrine, dihydroartermisinin, and piperaquine. A statistically significant correlation was found between 50% inhibitory concentration values of quinine and amodiaquine (r = 0.80; p < 0.0001). Conclusions Plasmodium falciparum isolates were highly sensitive to dihydroartermisinin, lumefantrine, and piperaquine and less sensitive to amodiaquine (n = 2), mefloquine (n = 1), and quinine (n = 19). Therefore, our data support the previously reported increasing trend in chloroquine sensitivity in Mali. | ||
546 | |a EN | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Drugs in R&D, Vol 20, Iss 3, Pp 249-255 (2020) | |
787 | 0 | |n https://doi.org/10.1007/s40268-020-00313-4 | |
787 | 0 | |n https://doaj.org/toc/1174-5886 | |
787 | 0 | |n https://doaj.org/toc/1179-6901 | |
856 | 4 | 1 | |u https://doaj.org/article/8ba7142356c048e289f3a19dc43e0a01 |z Connect to this object online. |